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enced a (biopsy proven) relapse. She went on to receive salvage
chemotherapy including carboplatin and cytoxan with stabiliza-
tion of disease, but without shrinkage in her tumor. Attempts to
collect peripheral blood stem cells upon recovery from chemo-
therapy using G-CSF at a dose of 24mcg/kg/day were unsuc-
cessful with only 1  105CD-34 positive stem cells per kg
collected over 3 days. In order to attempt to collect enough stem
cells for an autologous stem cell transplant, we obtained consent
from the AnorMED corporation and our institutional review
board for a PBSC collection using 4 days G-CSF at 10 mcg/kg
sc followed by 240 mcg/kg AMD3100 sc and subsequent aphere-
sis 10 hours later. We collected PBSCs for three days and
repeated this cycle a second time 30 days later, which allowed us
to collect 1.3  106CD34 positive stem cells per kg, more than
an order of magnitude greater than with G-CSF alone. There
were no untoward toxicities including no GI upset, paresthesias,
or injection site reactions, which have been previously reported
with adult patients. Pharmacokinetics were performed and were
similar to adults.
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IMPACT OF HIGH-RESOLUTION HLA MATCHING ON OUTCOMES OF
UNRELATED DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION
Jang, J.H.1, Kang, S.Y.1, Park, J.S.1, Choi, J.H.1, Lim, H.Y.1,
Kim, H.C.1 Department of Hematology-Oncology, Ajou University
School of Medicine, Suwon, Korea.
Objective: We assessed the impact of high-resolution geno-
typic results of human leukocyte antigen (HLA) for all major
class I and II loci between donors and recipients in the outcome
of unrelated hematopoietic stem cell transplantation (HSCT).
Methods: Between 1999 and 2005, high-resolution genotyping
for HLA-A, -B, -C and -DRB1 was performed for 23 unrelated
HSCT. All the patients were typed as HLA identical by sero-
logic technique and then they were also typed HLA identical by
high resolution technique. Unrelated bone marrow transplan-
tation using DNA-based high resolution HLA compatibilities
were considered in the analyses of clinical outcomes such as
hematopoietic engraftment, acute GVHD, and survival. And
then, we compared with patients who received related HSCT
and also unrelated HSCT data from IBMTR. Results: Median
follow up duration was 9 months (1–51). Fifteen patients were
male and 8 were female. Median age was 22 years (range 6–52).
Median time from diagnosis to transplantation was 7 months
(range 4–63). Eight patients of acute myeloid leukemia (AML),
6 of chronic myeloid leukemia (CML, 2 of 6 were in blast crisis),
4 of acute lymphoid leukemia (ALL), 3 of severe aplastic anemia,
and each case of juvenile myelomonocytic leukemia and myelo-
dysplastic syndrome were enrolled. Median value of total nu-
cleated cell and CD34 positive cell count was 3.51 (1.06–
20.7)  108/kg and 4.88 (1.33–46.9)  106/kg, respectively. The
conditioning regimen and prophylaxis for graft versus host dis-
ease (GVHD) were not different from conventional HSCT
except one case of non-myeloablative transplantation. Median
value of granulocytic (absolute granulocyte count 	500/mm3)
and platelet (	20,000/mm3) engraftment were D  16, D  17,
respectively. Grade II acute GVHD developed in 4 patients (2
patients subsequently proceeded to chronic GVHD). Treatment
related mortality was 8.7% (2 out of 23 patients). Median value
of overall survival duration was 30 months. For AML patients,
3-year survival rate was 72.9%. Conclusions: Our survival data
for unrelated HSCT based on high resolution genotyped HLA
matching was inferior to related HSCT and superior to unre-
lated HSCT (of as expected). Although the sample size is small,
the survival data of AML patients (CR1) was superior to the
survivals of related HSCT as well as that of unrelated HSCT.
We suggest that transplantation using unrelated donors selected
by high-resolution genotype identity improves the transplanta-
tion outcomes.
IMMUNE RECONSTITUTION
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TRANSCRIPTIONAL MAPPING OF THE ANTI-VIRAL T CELL RESPONSE
SHOWS THAT IMPAIRED MEMORY DIFFERENTIATION CAUSES T CELL
DYSFUNCTION
Haining, W.N.1, Ebert, B.1,2, Subramanian, A.2, Golub, T.1,2,
Kaech, S.3, Wherry, E.J.4, Nadler, L.M.1 1.Dana-Farber Cancer In-
stutute, Boston, MA; 2. Broad Institute of Harvard and MIT, Cam-
bridge, MA; 3. Yale University, New Haven, CT; 4. Wistar Institute,
Phliadelphia, PA.
Human T cells responding to viral pathogens after HSCT can be
dysfunctional and ineffective even when present in adequate num-
bers. The basis for this qualitative, rather than quantitative, T cell
defect is not known.We hypothesized that impaired differentiation
of naive T cells into memory T cells causes a qualitative T cell
defect. We, therefore, studied CD8 T cell memory differentiation
in 2 murine models of LCMV infection: an acute infection in
which virus-speciﬁc T cells are fully functional and a chronic
infection model in which T cells are present in normal numbers
but are dysfunctional. In order to deﬁne how the differentiation
state of dysfunctional T cells in chronic infection differ from those
in acute infection, we generated gene expression proﬁles from
naive (day 0), effector (day 7 [d7]), and memory (day 30 [d30]) T
cells using oligonucleotide microarrays. In acute infection, T cell
states were so distinct that 100% of naive, effector, and memory
samples could be correctly classiﬁed, using a k-Nearest-Neighbor
prediction classiﬁer (kNN). Next, we hypothesized that the signa-
ture of normal memory T cells would contain gene-sets known to
be important in memory differentiation. We found that Stat-5
target genes were the most enriched gene-sets in memory cells
relative to naive cells of 	400 gene-sets tested (P  .004 by
permutation testing). This is consistent with the central role of
Stat-5 signaling in memory development. Lastly, we determined
where dysfunctional d30 T cells from chronic infection lie relative
to the “differentiation-space” of acute infection. None of the
chronic d30 T cell samples were classiﬁed as memory by kNN
prediction; all were misclassiﬁed as effectors. However, chronic
d30 T cells were not simply persistent effectors because chronic
d30 T cells showed marked differences in gene expression pattern
compared to d7 effectors. Thus, dysfunctional T cells in chronic
viral infection fail to complete normal memory differentiation and
are arrested in a distinct, effector-like phase. Our results show that
the disruption of memory differentiation causes qualitative T cell
dysfunction, and that this altered differentiation can be detected by
gene-expression proﬁling. We are now generating a global map of
antigen-speciﬁc T cell differentiation in humans. This gene-ex-
pression-based approach to evaluating immune reconstitution will
identify the mechanisms limiting the recovery of T cell memory
after HSCT.
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EXPRESSION OF INDIVIDUAL KILLER IMMUNOGLOBULIN-LIKE RECEP-
TOR (KIR) GENES MEASURED BY QUANTITATIVE REAL-TIME-PCR DI-
VIDES BLOOD NATURAL KILLER (NK) CELLS INTO THREE DEVELOP-
MENTALLY DISTINCT POPULATIONS
Cooley, S.A.1, Xiao, F.1, Pitt, M.1, McCullar, V.1, Bergemann, T.L.1,
McQueen, K.2, Parham, P.2, Miller, J.S.1 1. University of Minnesota,
Minneapolis, MN; 2. Stanford University, Palo Alto, CA.
Although hematopoietic cell transplant strategies that use KIR-
ligand mismatching to generate alloreactive NK cells have been
associated with improved clinical outcomes, the contributing ef-
fects of the fundamental processes regulating individual KIR ex-
pression are poorly understood. To study KIR emergence during
NK cell reconstitution, we created and validated a novel Quanti-
tative Real Time PCR (Q-PCR) expression typing assay to mea-
sure comparative KIR mRNA expression at the single gene level.
TaqMan primers and probes were designed for 13 KIR genes and
compared to genotyping. Analysis of 435 reactions run on mononu-
clear cells (5–15% NK cells) from 36 normal volunteers showed
excellent concordance between expression typing and genotyping:
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